nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B3—Paclitaxel—lung cancer	0.0794	0.122	CbGbCtD
Pioglitazone—SLCO1B3—Docetaxel—lung cancer	0.0574	0.0883	CbGbCtD
Pioglitazone—SLCO1B1—Irinotecan—lung cancer	0.0456	0.0702	CbGbCtD
Pioglitazone—SLCO1B3—Methotrexate—lung cancer	0.0414	0.0637	CbGbCtD
Pioglitazone—CYP2C19—Gefitinib—lung cancer	0.0303	0.0466	CbGbCtD
Pioglitazone—CYP2C19—Teniposide—lung cancer	0.0294	0.0452	CbGbCtD
Pioglitazone—PTGS1—Etoposide—lung cancer	0.0268	0.0412	CbGbCtD
Pioglitazone—CYP2C9—Gefitinib—lung cancer	0.0252	0.0388	CbGbCtD
Pioglitazone—CYP2C9—Teniposide—lung cancer	0.0244	0.0376	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—lung cancer	0.0241	0.0371	CbGbCtD
Pioglitazone—CYP2D6—Gefitinib—lung cancer	0.0231	0.0355	CbGbCtD
Pioglitazone—CYP2C8—Erlotinib—lung cancer	0.0214	0.0329	CbGbCtD
Pioglitazone—CYP2C8—Paclitaxel—lung cancer	0.0196	0.0301	CbGbCtD
Pioglitazone—CYP2D6—Vinorelbine—lung cancer	0.0178	0.0273	CbGbCtD
Pioglitazone—CYP3A4—Topotecan—lung cancer	0.016	0.0247	CbGbCtD
Pioglitazone—CYP2C8—Etoposide—lung cancer	0.0155	0.0238	CbGbCtD
Pioglitazone—CYP3A4—Gefitinib—lung cancer	0.0147	0.0225	CbGbCtD
Pioglitazone—CYP3A4—Teniposide—lung cancer	0.0142	0.0219	CbGbCtD
Pioglitazone—CYP2C9—Paclitaxel—lung cancer	0.0136	0.021	CbGbCtD
Pioglitazone—CYP2D6—Erlotinib—lung cancer	0.0136	0.021	CbGbCtD
Pioglitazone—CYP3A4—Vinorelbine—lung cancer	0.0113	0.0174	CbGbCtD
Pioglitazone—CYP2C9—Cisplatin—lung cancer	0.011	0.0169	CbGbCtD
Pioglitazone—CYP2D6—Vinblastine—lung cancer	0.0109	0.0168	CbGbCtD
Pioglitazone—CYP3A4—Crizotinib—lung cancer	0.00898	0.0138	CbGbCtD
Pioglitazone—CYP3A4—Erlotinib—lung cancer	0.00867	0.0133	CbGbCtD
Pioglitazone—CYP3A4—Paclitaxel—lung cancer	0.00793	0.0122	CbGbCtD
Pioglitazone—CYP3A4—Irinotecan—lung cancer	0.00783	0.012	CbGbCtD
Pioglitazone—CYP3A4—Vinblastine—lung cancer	0.00696	0.0107	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—lung cancer	0.00672	0.0103	CbGbCtD
Pioglitazone—CYP3A4—Etoposide—lung cancer	0.00627	0.00964	CbGbCtD
Pioglitazone—CYP3A4—Docetaxel—lung cancer	0.00574	0.00882	CbGbCtD
Pioglitazone—CYP3A4—Doxorubicin—lung cancer	0.00428	0.00658	CbGbCtD
Pioglitazone—Rosiglitazone—CYP2A6—lung cancer	0.00206	0.719	CrCbGaD
Pioglitazone—PPARG—Irinotecan—Topotecan—lung cancer	0.00177	0.33	CbGdCrCtD
Pioglitazone—PPARG—Topotecan—Irinotecan—lung cancer	0.00147	0.274	CbGdCrCtD
Pioglitazone—PPARG—Etoposide—Teniposide—lung cancer	0.00146	0.272	CbGdCrCtD
Pioglitazone—Rosiglitazone—ALB—lung cancer	0.000805	0.281	CrCbGaD
Pioglitazone—PPARG—Teniposide—Etoposide—lung cancer	0.000662	0.124	CbGdCrCtD
Pioglitazone—Back pain—Paclitaxel—lung cancer	0.000173	0.000779	CcSEcCtD
Pioglitazone—Pharyngitis—Docetaxel—lung cancer	0.000173	0.000779	CcSEcCtD
Pioglitazone—Dizziness—Vinblastine—lung cancer	0.000172	0.000778	CcSEcCtD
Pioglitazone—Urticaria—Vinorelbine—lung cancer	0.000172	0.000777	CcSEcCtD
Pioglitazone—Urinary tract disorder—Docetaxel—lung cancer	0.000172	0.000775	CcSEcCtD
Pioglitazone—Muscle spasms—Paclitaxel—lung cancer	0.000172	0.000775	CcSEcCtD
Pioglitazone—Diarrhoea—Erlotinib—lung cancer	0.000171	0.000774	CcSEcCtD
Pioglitazone—Oedema peripheral—Docetaxel—lung cancer	0.000171	0.000773	CcSEcCtD
Pioglitazone—Connective tissue disorder—Docetaxel—lung cancer	0.000171	0.000771	CcSEcCtD
Pioglitazone—Nervous system disorder—Gemcitabine—lung cancer	0.000171	0.00077	CcSEcCtD
Pioglitazone—Urethral disorder—Docetaxel—lung cancer	0.00017	0.000769	CcSEcCtD
Pioglitazone—Myalgia—Cisplatin—lung cancer	0.000169	0.000764	CcSEcCtD
Pioglitazone—Skin disorder—Gemcitabine—lung cancer	0.000169	0.000763	CcSEcCtD
Pioglitazone—Ill-defined disorder—Etoposide—lung cancer	0.000169	0.000762	CcSEcCtD
Pioglitazone—Anaemia—Etoposide—lung cancer	0.000168	0.000759	CcSEcCtD
Pioglitazone—Hyperhidrosis—Gemcitabine—lung cancer	0.000168	0.000759	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000168	0.000758	CcSEcCtD
Pioglitazone—Visual impairment—Docetaxel—lung cancer	0.000168	0.000756	CcSEcCtD
Pioglitazone—Dizziness—Topotecan—lung cancer	0.000168	0.000756	CcSEcCtD
Pioglitazone—Liver function test abnormal—Methotrexate—lung cancer	0.000167	0.000754	CcSEcCtD
Pioglitazone—Discomfort—Cisplatin—lung cancer	0.000167	0.000754	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—lung cancer	0.000167	0.000753	CcSEcCtD
Pioglitazone—Dizziness—Erlotinib—lung cancer	0.000166	0.000748	CcSEcCtD
Pioglitazone—Ill-defined disorder—Paclitaxel—lung cancer	0.000166	0.000747	CcSEcCtD
Pioglitazone—Anaemia—Paclitaxel—lung cancer	0.000165	0.000745	CcSEcCtD
Pioglitazone—Malaise—Etoposide—lung cancer	0.000164	0.000741	CcSEcCtD
Pioglitazone—Breast disorder—Methotrexate—lung cancer	0.000164	0.000739	CcSEcCtD
Pioglitazone—Vertigo—Etoposide—lung cancer	0.000164	0.000738	CcSEcCtD
Pioglitazone—Headache—Vinblastine—lung cancer	0.000163	0.000737	CcSEcCtD
Pioglitazone—Angioedema—Paclitaxel—lung cancer	0.000163	0.000736	CcSEcCtD
Pioglitazone—Eye disorder—Docetaxel—lung cancer	0.000163	0.000733	CcSEcCtD
Pioglitazone—Anaphylactic shock—Cisplatin—lung cancer	0.000162	0.000732	CcSEcCtD
Pioglitazone—Oedema—Cisplatin—lung cancer	0.000162	0.000732	CcSEcCtD
Pioglitazone—Insomnia—Irinotecan—lung cancer	0.000162	0.000729	CcSEcCtD
Pioglitazone—Cardiac disorder—Docetaxel—lung cancer	0.000161	0.000728	CcSEcCtD
Pioglitazone—Infection—Cisplatin—lung cancer	0.000161	0.000727	CcSEcCtD
Pioglitazone—Malaise—Paclitaxel—lung cancer	0.000161	0.000726	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—lung cancer	0.000161	0.000725	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—lung cancer	0.000161	0.000725	CcSEcCtD
Pioglitazone—Vertigo—Paclitaxel—lung cancer	0.00016	0.000724	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—lung cancer	0.00016	0.000722	CcSEcCtD
Pioglitazone—Hypersensitivity—Vinorelbine—lung cancer	0.00016	0.00072	CcSEcCtD
Pioglitazone—Dyspnoea—Irinotecan—lung cancer	0.000159	0.000719	CcSEcCtD
Pioglitazone—Nervous system disorder—Cisplatin—lung cancer	0.000159	0.000718	CcSEcCtD
Pioglitazone—Headache—Topotecan—lung cancer	0.000159	0.000716	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000159	0.000715	CcSEcCtD
Pioglitazone—Skin disorder—Cisplatin—lung cancer	0.000158	0.000711	CcSEcCtD
Pioglitazone—Insomnia—Gemcitabine—lung cancer	0.000157	0.00071	CcSEcCtD
Pioglitazone—Hypertension—Etoposide—lung cancer	0.000157	0.000709	CcSEcCtD
Pioglitazone—Immune system disorder—Docetaxel—lung cancer	0.000157	0.000709	CcSEcCtD
Pioglitazone—Headache—Erlotinib—lung cancer	0.000157	0.000708	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—lung cancer	0.000157	0.000708	CcSEcCtD
Pioglitazone—Hyperhidrosis—Cisplatin—lung cancer	0.000157	0.000708	CcSEcCtD
Pioglitazone—Mediastinal disorder—Docetaxel—lung cancer	0.000157	0.000707	CcSEcCtD
Pioglitazone—Asthenia—Vinorelbine—lung cancer	0.000155	0.000701	CcSEcCtD
Pioglitazone—Dyspnoea—Gemcitabine—lung cancer	0.000155	0.0007	CcSEcCtD
Pioglitazone—Chest pain—Etoposide—lung cancer	0.000155	0.0007	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Irinotecan—lung cancer	0.000154	0.000696	CcSEcCtD
Pioglitazone—Hypertension—Paclitaxel—lung cancer	0.000154	0.000696	CcSEcCtD
Pioglitazone—Fatigue—Irinotecan—lung cancer	0.000154	0.000695	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000154	0.000695	CcSEcCtD
Pioglitazone—Discomfort—Etoposide—lung cancer	0.000153	0.000691	CcSEcCtD
Pioglitazone—Myalgia—Paclitaxel—lung cancer	0.000152	0.000686	CcSEcCtD
Pioglitazone—Arthralgia—Paclitaxel—lung cancer	0.000152	0.000686	CcSEcCtD
Pioglitazone—Chest pain—Paclitaxel—lung cancer	0.000152	0.000686	CcSEcCtD
Pioglitazone—Malnutrition—Docetaxel—lung cancer	0.000151	0.000683	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000151	0.000681	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00015	0.000678	CcSEcCtD
Pioglitazone—Discomfort—Paclitaxel—lung cancer	0.00015	0.000678	CcSEcCtD
Pioglitazone—Fatigue—Gemcitabine—lung cancer	0.00015	0.000677	CcSEcCtD
Pioglitazone—Anaphylactic shock—Etoposide—lung cancer	0.000149	0.000671	CcSEcCtD
Pioglitazone—Diarrhoea—Vinorelbine—lung cancer	0.000148	0.000669	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000148	0.000667	CcSEcCtD
Pioglitazone—Infection—Etoposide—lung cancer	0.000148	0.000666	CcSEcCtD
Pioglitazone—Feeling abnormal—Irinotecan—lung cancer	0.000147	0.000664	CcSEcCtD
Pioglitazone—Back pain—Docetaxel—lung cancer	0.000146	0.000661	CcSEcCtD
Pioglitazone—Anaphylactic shock—Paclitaxel—lung cancer	0.000146	0.000657	CcSEcCtD
Pioglitazone—Oedema—Paclitaxel—lung cancer	0.000146	0.000657	CcSEcCtD
Pioglitazone—Muscle spasms—Docetaxel—lung cancer	0.000146	0.000656	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Methotrexate—lung cancer	0.000146	0.000656	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—lung cancer	0.000145	0.000653	CcSEcCtD
Pioglitazone—Infection—Paclitaxel—lung cancer	0.000145	0.000653	CcSEcCtD
Pioglitazone—Dyspnoea—Cisplatin—lung cancer	0.000145	0.000653	CcSEcCtD
Pioglitazone—Skin disorder—Etoposide—lung cancer	0.000144	0.000651	CcSEcCtD
Pioglitazone—Erectile dysfunction—Methotrexate—lung cancer	0.000144	0.000651	CcSEcCtD
Pioglitazone—Hyperhidrosis—Etoposide—lung cancer	0.000144	0.000648	CcSEcCtD
Pioglitazone—Feeling abnormal—Gemcitabine—lung cancer	0.000143	0.000647	CcSEcCtD
Pioglitazone—Dizziness—Vinorelbine—lung cancer	0.000143	0.000646	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—lung cancer	0.000143	0.000646	CcSEcCtD
Pioglitazone—Nervous system disorder—Paclitaxel—lung cancer	0.000143	0.000645	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—lung cancer	0.000142	0.000639	CcSEcCtD
Pioglitazone—Skin disorder—Paclitaxel—lung cancer	0.000142	0.000639	CcSEcCtD
Pioglitazone—Hyperhidrosis—Paclitaxel—lung cancer	0.000141	0.000636	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Cisplatin—lung cancer	0.00014	0.000632	CcSEcCtD
Pioglitazone—Anaemia—Docetaxel—lung cancer	0.00014	0.000631	CcSEcCtD
Pioglitazone—Infestation NOS—Methotrexate—lung cancer	0.00014	0.00063	CcSEcCtD
Pioglitazone—Infestation—Methotrexate—lung cancer	0.00014	0.00063	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000138	0.000624	CcSEcCtD
Pioglitazone—Headache—Vinorelbine—lung cancer	0.000136	0.000612	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—lung cancer	0.000136	0.000612	CcSEcCtD
Pioglitazone—Sweating—Methotrexate—lung cancer	0.000134	0.000604	CcSEcCtD
Pioglitazone—Feeling abnormal—Cisplatin—lung cancer	0.000134	0.000603	CcSEcCtD
Pioglitazone—Haematuria—Methotrexate—lung cancer	0.000133	0.0006	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000133	0.000599	CcSEcCtD
Pioglitazone—Dyspnoea—Etoposide—lung cancer	0.000133	0.000598	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—lung cancer	0.000132	0.000596	CcSEcCtD
Pioglitazone—Insomnia—Paclitaxel—lung cancer	0.000132	0.000595	CcSEcCtD
Pioglitazone—Hypersensitivity—Irinotecan—lung cancer	0.000132	0.000594	CcSEcCtD
Pioglitazone—Hypertension—Docetaxel—lung cancer	0.000131	0.00059	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—lung cancer	0.00013	0.000588	CcSEcCtD
Pioglitazone—Dyspnoea—Paclitaxel—lung cancer	0.00013	0.000586	CcSEcCtD
Pioglitazone—Chest pain—Docetaxel—lung cancer	0.000129	0.000581	CcSEcCtD
Pioglitazone—Arthralgia—Docetaxel—lung cancer	0.000129	0.000581	CcSEcCtD
Pioglitazone—Myalgia—Docetaxel—lung cancer	0.000129	0.000581	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Etoposide—lung cancer	0.000128	0.000579	CcSEcCtD
Pioglitazone—Asthenia—Irinotecan—lung cancer	0.000128	0.000578	CcSEcCtD
Pioglitazone—Fatigue—Etoposide—lung cancer	0.000128	0.000578	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000128	0.000577	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000126	0.000568	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000126	0.000568	CcSEcCtD
Pioglitazone—Fatigue—Paclitaxel—lung cancer	0.000126	0.000567	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—lung cancer	0.000125	0.000565	CcSEcCtD
Pioglitazone—Asthenia—Gemcitabine—lung cancer	0.000125	0.000563	CcSEcCtD
Pioglitazone—Pharyngitis—Methotrexate—lung cancer	0.000124	0.000561	CcSEcCtD
Pioglitazone—Urinary tract disorder—Methotrexate—lung cancer	0.000124	0.000558	CcSEcCtD
Pioglitazone—Oedema—Docetaxel—lung cancer	0.000124	0.000557	CcSEcCtD
Pioglitazone—Anaphylactic shock—Docetaxel—lung cancer	0.000124	0.000557	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—lung cancer	0.000123	0.000557	CcSEcCtD
Pioglitazone—Urethral disorder—Methotrexate—lung cancer	0.000123	0.000554	CcSEcCtD
Pioglitazone—Infection—Docetaxel—lung cancer	0.000123	0.000554	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—lung cancer	0.000123	0.000553	CcSEcCtD
Pioglitazone—Feeling abnormal—Etoposide—lung cancer	0.000123	0.000553	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—lung cancer	0.000122	0.000552	CcSEcCtD
Pioglitazone—Diarrhoea—Irinotecan—lung cancer	0.000122	0.000552	CcSEcCtD
Pioglitazone—Nervous system disorder—Docetaxel—lung cancer	0.000121	0.000547	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—lung cancer	0.000121	0.000545	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—lung cancer	0.000121	0.000545	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—lung cancer	0.000121	0.000545	CcSEcCtD
Pioglitazone—Feeling abnormal—Paclitaxel—lung cancer	0.00012	0.000542	CcSEcCtD
Pioglitazone—Skin disorder—Docetaxel—lung cancer	0.00012	0.000541	CcSEcCtD
Pioglitazone—Hypersensitivity—Cisplatin—lung cancer	0.00012	0.000539	CcSEcCtD
Pioglitazone—Diarrhoea—Gemcitabine—lung cancer	0.000119	0.000537	CcSEcCtD
Pioglitazone—Dizziness—Irinotecan—lung cancer	0.000118	0.000533	CcSEcCtD
Pioglitazone—Urticaria—Etoposide—lung cancer	0.000118	0.000533	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—lung cancer	0.000118	0.00053	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—lung cancer	0.000117	0.000528	CcSEcCtD
Pioglitazone—Asthenia—Cisplatin—lung cancer	0.000116	0.000525	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—lung cancer	0.000116	0.000525	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—lung cancer	0.000116	0.000523	CcSEcCtD
Pioglitazone—Urticaria—Paclitaxel—lung cancer	0.000116	0.000522	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—lung cancer	0.000115	0.00052	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—lung cancer	0.000113	0.000512	CcSEcCtD
Pioglitazone—Immune system disorder—Methotrexate—lung cancer	0.000113	0.000511	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—lung cancer	0.000113	0.00051	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000113	0.000508	CcSEcCtD
Pioglitazone—Headache—Irinotecan—lung cancer	0.000112	0.000505	CcSEcCtD
Pioglitazone—Insomnia—Docetaxel—lung cancer	0.000112	0.000504	CcSEcCtD
Pioglitazone—Diarrhoea—Cisplatin—lung cancer	0.000111	0.000501	CcSEcCtD
Pioglitazone—Dyspnoea—Docetaxel—lung cancer	0.00011	0.000497	CcSEcCtD
Pioglitazone—Hypersensitivity—Etoposide—lung cancer	0.00011	0.000494	CcSEcCtD
Pioglitazone—Malnutrition—Methotrexate—lung cancer	0.000109	0.000492	CcSEcCtD
Pioglitazone—Headache—Gemcitabine—lung cancer	0.000109	0.000492	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—lung cancer	0.000109	0.00049	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—lung cancer	0.000108	0.000487	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—lung cancer	0.000108	0.000486	CcSEcCtD
Pioglitazone—Hypersensitivity—Paclitaxel—lung cancer	0.000107	0.000484	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—lung cancer	0.000107	0.000483	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—lung cancer	0.000107	0.000482	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000107	0.000481	CcSEcCtD
Pioglitazone—Asthenia—Etoposide—lung cancer	0.000107	0.000481	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—lung cancer	0.000107	0.000481	CcSEcCtD
Pioglitazone—Fatigue—Docetaxel—lung cancer	0.000107	0.00048	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—lung cancer	0.000106	0.00048	CcSEcCtD
Pioglitazone—Back pain—Methotrexate—lung cancer	0.000106	0.000476	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—lung cancer	0.000105	0.000472	CcSEcCtD
Pioglitazone—Asthenia—Paclitaxel—lung cancer	0.000105	0.000472	CcSEcCtD
Pioglitazone—Feeling abnormal—Docetaxel—lung cancer	0.000102	0.000459	CcSEcCtD
Pioglitazone—Diarrhoea—Etoposide—lung cancer	0.000102	0.000459	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—lung cancer	0.000101	0.000457	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methotrexate—lung cancer	0.000101	0.000457	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—lung cancer	0.000101	0.000455	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—lung cancer	0.000101	0.000454	CcSEcCtD
Pioglitazone—Diarrhoea—Paclitaxel—lung cancer	9.97e-05	0.00045	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—lung cancer	9.84e-05	0.000444	CcSEcCtD
Pioglitazone—Dizziness—Etoposide—lung cancer	9.83e-05	0.000443	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—lung cancer	9.8e-05	0.000442	CcSEcCtD
Pioglitazone—Vertigo—Methotrexate—lung cancer	9.8e-05	0.000442	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—lung cancer	9.78e-05	0.000441	CcSEcCtD
Pioglitazone—Dizziness—Paclitaxel—lung cancer	9.64e-05	0.000435	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—lung cancer	9.45e-05	0.000426	CcSEcCtD
Pioglitazone—Headache—Etoposide—lung cancer	9.31e-05	0.00042	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—lung cancer	9.31e-05	0.00042	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—lung cancer	9.29e-05	0.000419	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—lung cancer	9.29e-05	0.000419	CcSEcCtD
Pioglitazone—Arthralgia—Methotrexate—lung cancer	9.29e-05	0.000419	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.22e-05	0.000416	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—lung cancer	9.18e-05	0.000414	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—lung cancer	9.14e-05	0.000412	CcSEcCtD
Pioglitazone—Headache—Paclitaxel—lung cancer	9.13e-05	0.000412	CcSEcCtD
Pioglitazone—Hypersensitivity—Docetaxel—lung cancer	9.1e-05	0.000411	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—lung cancer	9.08e-05	0.00041	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—lung cancer	8.9e-05	0.000402	CcSEcCtD
Pioglitazone—Asthenia—Docetaxel—lung cancer	8.86e-05	0.0004	CcSEcCtD
Pioglitazone—Infection—Methotrexate—lung cancer	8.85e-05	0.000399	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—lung cancer	8.77e-05	0.000395	CcSEcCtD
Pioglitazone—Nervous system disorder—Methotrexate—lung cancer	8.73e-05	0.000394	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—lung cancer	8.73e-05	0.000394	CcSEcCtD
Pioglitazone—Skin disorder—Methotrexate—lung cancer	8.65e-05	0.00039	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methotrexate—lung cancer	8.61e-05	0.000388	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—lung cancer	8.52e-05	0.000384	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—lung cancer	8.49e-05	0.000383	CcSEcCtD
Pioglitazone—Diarrhoea—Docetaxel—lung cancer	8.45e-05	0.000381	CcSEcCtD
Pioglitazone—Dizziness—Docetaxel—lung cancer	8.17e-05	0.000369	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—lung cancer	8.16e-05	0.000368	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—lung cancer	8.11e-05	0.000366	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—lung cancer	8.05e-05	0.000363	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—lung cancer	8.04e-05	0.000363	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—lung cancer	8.04e-05	0.000363	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—lung cancer	8.04e-05	0.000363	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.99e-05	0.00036	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—lung cancer	7.95e-05	0.000358	CcSEcCtD
Pioglitazone—Dyspnoea—Methotrexate—lung cancer	7.94e-05	0.000358	CcSEcCtD
Pioglitazone—Headache—Docetaxel—lung cancer	7.74e-05	0.000349	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—lung cancer	7.71e-05	0.000348	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—lung cancer	7.71e-05	0.000348	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Methotrexate—lung cancer	7.69e-05	0.000347	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—lung cancer	7.68e-05	0.000346	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—lung cancer	7.66e-05	0.000346	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—lung cancer	7.56e-05	0.000341	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—lung cancer	7.49e-05	0.000338	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—lung cancer	7.45e-05	0.000336	CcSEcCtD
Pioglitazone—Feeling abnormal—Methotrexate—lung cancer	7.34e-05	0.000331	CcSEcCtD
Pioglitazone—Urticaria—Methotrexate—lung cancer	7.07e-05	0.000319	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.02e-05	0.000317	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—lung cancer	6.97e-05	0.000315	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—lung cancer	6.87e-05	0.00031	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—lung cancer	6.66e-05	0.0003	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—lung cancer	6.65e-05	0.0003	CcSEcCtD
Pioglitazone—Hypersensitivity—Methotrexate—lung cancer	6.56e-05	0.000296	CcSEcCtD
Pioglitazone—Asthenia—Methotrexate—lung cancer	6.39e-05	0.000288	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—lung cancer	6.35e-05	0.000287	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—lung cancer	6.13e-05	0.000276	CcSEcCtD
Pioglitazone—Diarrhoea—Methotrexate—lung cancer	6.09e-05	0.000275	CcSEcCtD
Pioglitazone—Dizziness—Methotrexate—lung cancer	5.89e-05	0.000266	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—lung cancer	5.68e-05	0.000256	CcSEcCtD
Pioglitazone—Headache—Methotrexate—lung cancer	5.58e-05	0.000252	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—lung cancer	5.53e-05	0.00025	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—lung cancer	5.28e-05	0.000238	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—lung cancer	5.1e-05	0.00023	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—lung cancer	4.83e-05	0.000218	CcSEcCtD
Pioglitazone—CYP2C19—Metabolism—ALDOA—lung cancer	1.24e-05	0.000103	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GCLC—lung cancer	1.23e-05	0.000102	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP2A6—lung cancer	1.23e-05	0.000102	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—UGT1A1—lung cancer	1.23e-05	0.000102	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTM1—lung cancer	1.23e-05	0.000102	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.22e-05	0.000102	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTMR3—lung cancer	1.22e-05	0.000102	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CREBBP—lung cancer	1.21e-05	0.0001	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NCOA3—lung cancer	1.2e-05	0.0001	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GNG11—lung cancer	1.19e-05	9.95e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PGAM1—lung cancer	1.19e-05	9.92e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GNG11—lung cancer	1.18e-05	9.86e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.18e-05	9.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.18e-05	9.81e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CB—lung cancer	1.17e-05	9.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCG2—lung cancer	1.17e-05	9.72e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ADCY1—lung cancer	1.17e-05	9.72e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ENO1—lung cancer	1.17e-05	9.71e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1A1—lung cancer	1.16e-05	9.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.16e-05	9.67e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—lung cancer	1.16e-05	9.64e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ERCC2—lung cancer	1.15e-05	9.61e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.15e-05	9.55e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ENO2—lung cancer	1.14e-05	9.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HPGDS—lung cancer	1.14e-05	9.54e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CD—lung cancer	1.14e-05	9.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.14e-05	9.48e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALDOA—lung cancer	1.14e-05	9.47e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2A7—lung cancer	1.14e-05	9.46e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—lung cancer	1.13e-05	9.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALDOA—lung cancer	1.13e-05	9.39e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.12e-05	9.35e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—APOA1—lung cancer	1.12e-05	9.34e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SDC4—lung cancer	1.11e-05	9.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTT1—lung cancer	1.11e-05	9.25e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NCOA3—lung cancer	1.1e-05	9.19e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP2A6—lung cancer	1.1e-05	9.14e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GCLC—lung cancer	1.1e-05	9.14e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NCOA3—lung cancer	1.09e-05	9.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.09e-05	9.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.08e-05	8.96e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.07e-05	8.95e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ADCY1—lung cancer	1.07e-05	8.94e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCG2—lung cancer	1.07e-05	8.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ADCY1—lung cancer	1.06e-05	8.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCG2—lung cancer	1.06e-05	8.87e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HPGDS—lung cancer	1.05e-05	8.77e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ENO2—lung cancer	1.05e-05	8.77e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.05e-05	8.72e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP2E1—lung cancer	1.05e-05	8.71e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ENO2—lung cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HPGDS—lung cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ENO1—lung cancer	1.04e-05	8.67e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.04e-05	8.64e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.04e-05	8.63e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NQO1—lung cancer	1.03e-05	8.61e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CG—lung cancer	1.02e-05	8.53e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.02e-05	8.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.02e-05	8.52e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTT1—lung cancer	1.02e-05	8.51e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—RRM1—lung cancer	1.01e-05	8.44e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA3—lung cancer	1.01e-05	8.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTT1—lung cancer	1.01e-05	8.43e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.01e-05	8.43e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GCLC—lung cancer	1.01e-05	8.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP2A6—lung cancer	1.01e-05	8.41e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—lung cancer	1.01e-05	8.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1e-05	8.35e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GCLC—lung cancer	1e-05	8.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2A6—lung cancer	1e-05	8.34e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOA1—lung cancer	9.98e-06	8.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.97e-06	8.3e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CB—lung cancer	9.96e-06	8.3e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—lung cancer	9.87e-06	8.22e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—POMC—lung cancer	9.74e-06	8.12e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—EP300—lung cancer	9.62e-06	8.02e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ENO1—lung cancer	9.57e-06	7.97e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.55e-06	7.96e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—B4GALT5—lung cancer	9.52e-06	7.93e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CREBBP—lung cancer	9.49e-06	7.91e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ENO1—lung cancer	9.49e-06	7.9e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAPK3—lung cancer	9.46e-06	7.88e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.45e-06	7.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP2E1—lung cancer	9.33e-06	7.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.33e-06	7.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—STK11—lung cancer	9.32e-06	7.76e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA4—lung cancer	9.26e-06	7.72e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NQO1—lung cancer	9.23e-06	7.69e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—lung cancer	9.2e-06	7.66e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CG—lung cancer	9.11e-06	7.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.03e-06	7.53e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA2—lung cancer	9.03e-06	7.52e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CD—lung cancer	9e-06	7.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.95e-06	7.46e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—lung cancer	8.88e-06	7.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.75e-06	7.29e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA1—lung cancer	8.71e-06	7.25e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—POMC—lung cancer	8.67e-06	7.22e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—lung cancer	8.62e-06	7.18e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCC3—lung cancer	8.61e-06	7.17e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—lung cancer	8.61e-06	7.17e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP2E1—lung cancer	8.58e-06	7.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2E1—lung cancer	8.51e-06	7.09e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NQO1—lung cancer	8.49e-06	7.07e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CREBBP—lung cancer	8.44e-06	7.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NQO1—lung cancer	8.41e-06	7.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CAT—lung cancer	8.39e-06	6.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.34e-06	6.95e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKR1C1—lung cancer	8.34e-06	6.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—STK11—lung cancer	8.32e-06	6.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.24e-06	6.86e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—EP300—lung cancer	8.21e-06	6.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.16e-06	6.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCB1—lung cancer	8.16e-06	6.8e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—UGT1A1—lung cancer	8.1e-06	6.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TYMS—lung cancer	8.01e-06	6.68e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CD—lung cancer	8.01e-06	6.67e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—lung cancer	7.92e-06	6.6e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—lung cancer	7.9e-06	6.58e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CB—lung cancer	7.84e-06	6.53e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.81e-06	6.5e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GNG11—lung cancer	7.81e-06	6.5e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—lung cancer	7.77e-06	6.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—lung cancer	7.7e-06	6.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—STK11—lung cancer	7.65e-06	6.37e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—STK11—lung cancer	7.58e-06	6.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A1—lung cancer	7.51e-06	6.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CAT—lung cancer	7.49e-06	6.24e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ERCC2—lung cancer	7.45e-06	6.21e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.45e-06	6.2e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDOA—lung cancer	7.43e-06	6.19e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCB1—lung cancer	7.28e-06	6.07e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA3—lung cancer	7.22e-06	6.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TYMS—lung cancer	7.15e-06	5.96e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.12e-06	5.93e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—lung cancer	7.12e-06	5.93e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—lung cancer	7.08e-06	5.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—lung cancer	7.07e-06	5.89e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ADCY1—lung cancer	7.02e-06	5.85e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCG2—lung cancer	7.02e-06	5.85e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—lung cancer	7.02e-06	5.85e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CB—lung cancer	6.98e-06	5.81e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—lung cancer	6.91e-06	5.76e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CAT—lung cancer	6.89e-06	5.74e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ENO2—lung cancer	6.88e-06	5.73e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HPGDS—lung cancer	6.88e-06	5.73e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPP2R1B—lung cancer	6.84e-06	5.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CAT—lung cancer	6.83e-06	5.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.79e-06	5.66e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—lung cancer	6.78e-06	5.65e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A1—lung cancer	6.7e-06	5.58e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCB1—lung cancer	6.7e-06	5.58e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTT1—lung cancer	6.68e-06	5.56e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ERCC2—lung cancer	6.65e-06	5.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCB1—lung cancer	6.64e-06	5.53e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GCLC—lung cancer	6.6e-06	5.5e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2A6—lung cancer	6.6e-06	5.5e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TYMS—lung cancer	6.58e-06	5.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TYMS—lung cancer	6.52e-06	5.43e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—lung cancer	6.5e-06	5.42e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—EP300—lung cancer	6.46e-06	5.39e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—lung cancer	6.45e-06	5.37e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOA1—lung cancer	6.44e-06	5.37e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—lung cancer	6.38e-06	5.31e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ENO1—lung cancer	6.26e-06	5.21e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.17e-06	5.14e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A1—lung cancer	6.17e-06	5.14e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ERCC2—lung cancer	6.12e-06	5.09e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A1—lung cancer	6.11e-06	5.09e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—lung cancer	6.07e-06	5.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ERCC2—lung cancer	6.06e-06	5.05e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—lung cancer	6.03e-06	5.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CG—lung cancer	5.88e-06	4.9e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—lung cancer	5.81e-06	4.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOA1—lung cancer	5.75e-06	4.79e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—EP300—lung cancer	5.75e-06	4.79e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2E1—lung cancer	5.61e-06	4.67e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—POMC—lung cancer	5.6e-06	4.66e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NQO1—lung cancer	5.55e-06	4.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.51e-06	4.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CREBBP—lung cancer	5.45e-06	4.54e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOA1—lung cancer	5.29e-06	4.41e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CG—lung cancer	5.25e-06	4.37e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOA1—lung cancer	5.24e-06	4.37e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CD—lung cancer	5.17e-06	4.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—lung cancer	5.11e-06	4.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.02e-06	4.18e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—STK11—lung cancer	5e-06	4.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—POMC—lung cancer	5e-06	4.16e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—lung cancer	4.96e-06	4.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CREBBP—lung cancer	4.87e-06	4.06e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CG—lung cancer	4.83e-06	4.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CG—lung cancer	4.79e-06	3.99e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—lung cancer	4.78e-06	3.98e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—lung cancer	4.63e-06	3.85e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CD—lung cancer	4.62e-06	3.85e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—POMC—lung cancer	4.6e-06	3.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—POMC—lung cancer	4.56e-06	3.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—lung cancer	4.56e-06	3.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CB—lung cancer	4.51e-06	3.76e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CAT—lung cancer	4.5e-06	3.75e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CREBBP—lung cancer	4.48e-06	3.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—lung cancer	4.47e-06	3.72e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CREBBP—lung cancer	4.44e-06	3.7e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCB1—lung cancer	4.38e-06	3.65e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TYMS—lung cancer	4.3e-06	3.58e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—lung cancer	4.25e-06	3.54e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—lung cancer	4.25e-06	3.54e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CD—lung cancer	4.25e-06	3.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CD—lung cancer	4.21e-06	3.51e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—lung cancer	4.19e-06	3.49e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—lung cancer	4.15e-06	3.46e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A1—lung cancer	4.03e-06	3.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CB—lung cancer	4.02e-06	3.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ERCC2—lung cancer	4e-06	3.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—lung cancer	3.99e-06	3.32e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—lung cancer	3.91e-06	3.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—lung cancer	3.9e-06	3.24e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—EP300—lung cancer	3.71e-06	3.09e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CB—lung cancer	3.7e-06	3.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CB—lung cancer	3.67e-06	3.06e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—lung cancer	3.67e-06	3.05e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—lung cancer	3.64e-06	3.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—lung cancer	3.48e-06	2.9e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—lung cancer	3.48e-06	2.9e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA1—lung cancer	3.46e-06	2.88e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—EP300—lung cancer	3.32e-06	2.76e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—lung cancer	3.2e-06	2.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—lung cancer	3.17e-06	2.64e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CG—lung cancer	3.16e-06	2.63e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—EP300—lung cancer	3.05e-06	2.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—EP300—lung cancer	3.02e-06	2.52e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—POMC—lung cancer	3.01e-06	2.5e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CREBBP—lung cancer	2.93e-06	2.44e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CD—lung cancer	2.78e-06	2.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—lung cancer	2.75e-06	2.29e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—lung cancer	2.74e-06	2.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—lung cancer	2.45e-06	2.04e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CB—lung cancer	2.42e-06	2.02e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—lung cancer	2.4e-06	2e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—lung cancer	2.26e-06	1.88e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—lung cancer	2.24e-06	1.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—lung cancer	2.24e-06	1.86e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—lung cancer	2.09e-06	1.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—lung cancer	2e-06	1.67e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—EP300—lung cancer	1.99e-06	1.66e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—lung cancer	1.84e-06	1.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—lung cancer	1.83e-06	1.52e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.47e-06	1.23e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—lung cancer	1.2e-06	1e-05	CbGpPWpGaD
